- Quality control and quality assurance
- Pharmaceutical quality control
- Scope of Pharmaceutical Analysis and Quality Assurance
Pharmaceutical analysis is a process that is used for detection, determination, separation, purification, and structure elucidation of a given compound that is used in the formulation of pharmaceutical substances.
It is also called analytical chemistry that deals with the drugs both as bulk drug substances and as pharmaceutical formulations. Product analysis deals with the various formulations used for toxicological studies, clinical studies, and marketing.
Based on the determination, pharmaceutical analytical methods are of two types. They are:
- Quantitative analysis
- Qualitative analysis
Quality assurance is defined as a planned and systematic activity that is implemented within the quality system which can be demonstrated to provide confidence that a product or a service will fulfill the quality requirements. It is a system for evaluating performance, service, or the quality of a product against the system, standard or specified requirement for customers.
Luis Jesus Villarreal Gomez
FCITEC - Universidad Autónoma de Baja California, Mexico
Thomas J. Webster
School of Health Sciences and Biomedical Engineering and Mansfield Bioincubator, China
Miroslav Radenkovic
University of Belgrade, Serbia
A C Matin
Stanford University, United States
Luis Jesus Villarreal Gomez
FCITEC - Universidad Autónoma de Baja California, Mexico
Miroslav Radenkovic
University of Belgrade, Serbia
A C Matin
Stanford University, United States
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Andreas M Papas
Antares Health Products, United States
Consolato M Sergi
University of Ottawa, CanadaSubmit your abstract Today
Title : Nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, present successes and future prospects
A C Matin, Stanford University, United States
Title : Personalized and precision medicine (PPM) as a unique healthcare model to be set up via biodesign, bio- and chemical engineering, translational applications, and upgraded business modeling to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Preparation and characterization of fibers crafted from PCL/PVP-ChAgG, coupled with investigating their suitability as wound dressings.
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico
Title : Is your drug delivery formulation harming the environment ? Approaches to both save human health and the environment
Thomas J. Webster, School of Health Sciences and Biomedical Engineering and Mansfield Bioincubator, China
Title : Clinical pharmacology of aprocitentan (an endothelin receptor antagonist) – The most recent quality progress in treatment of resistant hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Clinical decision making in advanced and metastatic breast cancer cases between PARP inhibitors and CDK4/6 inhibitors
Priya Hays, Hays Documentation Specialists, LLC, United States
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Novel nano drug platform for pharmacologically inducing therapeutic hypothermia (TH) after traumatic brain injury (TBI)
Jorge David Tovar Castro, University of Miami Miller School of Medicine, United States
Title : Global drug development - Trends, challenges and opportunities
Gurpreet Singh, IQVIA, United Kingdom
Title : Drug design for the development of long-acting injectables
Thomas Ullrich, Novartis Biomedical Research, Switzerland